CIM
KIN

CIM Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History

CIM Investment Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35,630
Closed -$177K – 337
2021
Q1 		$177K Sell
35,630
-2,124
-6% -$10.3K 0.06% 292
2020
Q4 		$163K Hold
37,754
– – 0.05% 280
2020
Q3 		$162K Buy
37,754
+546
+1% +$2.28K 0.06% 244
2020
Q2 		$167K Buy
+37,208
New +$166K 0.07% 232

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

CIM Investment Management's KIN Position: Q2 2021 in Review

CIM Investment Management sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 35,630 shares — an estimated $177K sold.

CIM Investment Management first reported a position in KIN in Q2 2020 and held it in 4 quarters. The position peaked at $177K in Q1 2021. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • CIM Investment Management reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • CIM Investment Management sold 35,630 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $177K.
  • CIM Investment Management first reported a position in Kindred Biosciences, Inc. in Q2 2020 and held it in 4 quarters.
  • CIM Investment Management's Kindred Biosciences, Inc. position peaked at $177K in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on CIM Investment Management's 13F filing for Q2 2021, filed 13 Aug 2021.